SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Littlejohn Fund II LP, et al. – ‘SC 13D/A’ on 5/29/01 re: Pameco Corp

On:  Tuesday, 5/29/01, at 5:10pm ET   ·   Accession #:  1036050-1-500715   ·   File #:  5-51675

Previous ‘SC 13D’:  ‘SC 13D/A’ on 3/7/01   ·   Latest ‘SC 13D’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/29/01  Littlejohn Fund II LP             SC 13D/A               1:8K   Pameco Corp                       Donnelley R R & S… 14/FA
          Angus C. Littlejohn, Jr.
          Littlejohn Assoc. II, L.L.C.
          Littlejohn Fund II LP
          Littlejohn Fund II, L.P.
          Quilvest American Equity Ltd.

Amendment to General Statement of Beneficial Ownership   —   Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D/A    Pameco Corporation Schedule 13D/A                      3     15K 


Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
2Item 3. Source and Amount of Funds or Other Consideration
"Item 5. Interest in Securities of the Issuer
SC 13D/A1st Page of 3TOCTopPreviousNextBottomJust 1st
 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 7) Under the Securities Exchange Act of 1934 PAMECO CORPORATION ------------------ (Name of Issuer) COMMON STOCK, PAR VALUE $0.01 PER SHARE --------------------------------------- (Title of Class of Securities) 697934305 --------- (CUSIP Number) Angus C. Littlejohn, Jr. Littlejohn & Co., L.L.C. 115 East Putnam Avenue Greenwich, Connecticut 06830 (203) 552-3500 -------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) May 29, 2001 ------------ (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D/A, and is filing this schedule because of Rule 13D/A-1(b)(3) or (4), check the following box [_] Check the following box if a fee is being paid with the statement. [_] (A fee is not required only if the reporting person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13D/A-7.) The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 3
SC 13D/A2nd Page of 3TOC1stPreviousNextBottomJust 2nd
This Amendment No. 7 to the Statement on Schedule 13D (this "Statement"), which is being filed jointly by the Reporting Persons, also constitutes Amendment No. 11 to the Statement on Schedule 13D, as amended, previously filed by Quilvest American Equity Ltd. ("Quilvest") with respect to shares of Class A Common Stock, par value $.01 per share ("Class A Common Stock"), of Pameco Corporation, a Georgia corporation. Immediately prior to the Merger (as defined below) the Class A Common Stock was denominated as Common Stock, par value $.01 per share (the "Common Stock"), of Pameco Corporation, a Delaware corporation (the "Company"). This Statement amends the previously filed Statement on Schedule 13D filed by the Reporting Persons. The previously filed Statement included as a Reporting Person Pameco Acquisition, Inc., a Delaware corporation ("Merger Sub"). Because Merger Sub, as a result of the Merger, has been merged into the Company, it is no longer a Reporting Person. Information in this Statement with respect to Quilvest or its affiliates has been provided by Quilvest. Information in this Statement with respect to the other Reporting Persons has been provided by such other Reporting Persons. This is the final amendment of this Statement. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. Pursuant to an Agreement and Plan of Merger dated March 6, 2001 (the "Merger Agreement") providing for the merger (the "Merger") of Merger Sub with and into the Company, Littlejohn and Quilvest contributed to Merger Sub the funds needed to pay the Merger Consideration (as defined below). Approximately $1,395,080 was required to pay the Merger Consideration to holders of Common Stock of the Company at the closing of the Merger. All funds used to pay the Merger Consideration were from Buyers' internal funding sources. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. At a special meeting of the stockholders of the Company held on May 29, 2001, the Merger Agreement was approved by the affirmative vote of a majority of the votes cast by the holders of shares of voting stock entitled to vote at the special meeting. A certificate of merger was filed with respect to the Merger with the Secretary of State of the State of Delaware on May 29, 2001. At the effective time of the Merger (May 29, 2001), pursuant to the terms of the Merger Agreement, (a) each outstanding share of Common Stock was cancelled and converted into the right to receive $0.45 in cash (the "Merger Consideration") (except for (i) any shares held by a holder who had taken all actions required to perfect such holder's appraisal rights under Delaware law, (ii) any shares held by the Company as treasury shares, (iii) any shares held by Merger Sub and (iv) any shares held by a subsidiary of the Company, which shares in the cases of (ii) - (iv) were cancelled and retired); (b) each outstanding share of common stock, par value $0.01 per share, of Merger Sub was cancelled and converted into that number of shares of common stock, par value $0.01 per share, of the Company as the surviving corporation of the Merger equal to the nearest higher whole number to the quotient of (x) the number of shares of Common Stock outstanding at the effective time of the Merger, divided by (y) 10; and (c) each outstanding share of Series A Cumulative Pay-in-Kind Preferred Stock, par value $1.00 per share, of the Company, Series B Cumulative Pay-in-Kind Convertible Preferred Stock, par value $1.00 per share, of the Company, and Series C Cumulative Pay- in-Kind Convertible Preferred Stock, par value $1.00 per share, of the Company remains outstanding and was not exchanged, cancelled or modified in the Merger. A Form 15 has been filed with the Commission in order to deregister the Common Stock. A press release relating to the foregoing is being filed as an exhibit to the Amendment No. 3 - Final Amendment to the Schedule 13E-3 Transaction Statement being filed by the Company and others simultaneously with the filing of this document. Page 2 of 3
SC 13D/ALast Page of 3TOC1stPreviousNextBottomJust 3rd
SIGNATURE --------- After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct. Date: May 29, 2001 Littlejohn Fund II, L.P. By: Littlejohn Associates II, L.L.C., General Partner By: /s/ Angus C. Littlejohn, Jr. ------------------------------------ Name: Angus C. Littlejohn, Jr. Title: Manager Littlejohn Associates II, L.L.C. By: /s/ Angus C. Littlejohn, Jr. ------------------------------------ Name: Angus C. Littlejohn, Jr. Title: Manager /s/ Angus C. Littlejohn, Jr. --------------------------------------- Angus C. Littlejohn, Jr., individually Quilvest American Equity Ltd. By: /s/ Willem F.P. de Vogel ---------------------------------- Name: Willem F.P. de Vogel Title: Attorney-in-Fact Page 3 of 3

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘SC 13D/A’ Filing    Date First  Last      Other Filings
Filed on:5/29/011315-12B,  8-K,  S-8 POS,  SC 13E3/A
3/6/012
 List all Filings 
Top
Filing Submission 0001036050-01-500715   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 5:05:53.1pm ET